title: High Epstein-Barr virus-specific T-cell counts are associated with near-zero likelihood of acute myeloid leukemia relapse after hematopoietic cell transplantation.
authors.forename: M
authors.initials: M
authors.lastname: Hoegh-Petersen
authors.forename: S
authors.initials: S
authors.lastname: Sy
authors.forename: A
authors.initials: A
authors.lastname: Ugarte-Torres
authors.forename: T S
authors.initials: TS
authors.lastname: Williamson
authors.forename: M
authors.initials: M
authors.lastname: Eliasziw
authors.forename: A
authors.initials: A
authors.lastname: Mansoor
authors.forename: Y
authors.initials: Y
authors.lastname: Liu
authors.forename: S
authors.initials: S
authors.lastname: Liu
authors.forename: P
authors.initials: P
authors.lastname: Podgorny
authors.forename: F
authors.initials: F
authors.lastname: Khan
authors.forename: P R
authors.initials: PR
authors.lastname: Duggan
authors.forename: D A
authors.initials: DA
authors.lastname: Stewart
authors.forename: J A
authors.initials: JA
authors.lastname: Russell
authors.forename: J
authors.initials: J
authors.lastname: Storek
mesh_terms: D018380:Hematopoietic Stem Cell Transplantation; D004854:Herpesvirus 4, Human / Q000302:isolation & purification*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000276:immunology / Q000601:surgery* / Q000821:virology; D016013:Likelihood Functions; D018655:Lymphocyte Count; D012008:Recurrence; D013601:T-Lymphocytes / Q000276:immunology*